Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Gleamer is a pioneering medical technology company developing AI-driven software solutions to enhance diagnostic capabilities in radiology. Their flagship products, BoneView® for trauma X-rays and ChestView® for chest X-rays, assist radiologists by automatically detecting potential abnormalities, aiming to improve diagnostic accuracy, reduce reading times, and optimize workflow. Gleamer's mission is to empower healthcare professionals with advanced AI tools, ultimately contributing to better patient care and outcomes by tackling the challenges of increasing image volumes and the need for precise, timely diagnoses.
The Paris headquarters serves as the central hub for research and development, product innovation, strategic planning, and global operations management.
Situated in a historic Parisian building, the office likely combines classic architecture with modern, agile workspace design, fostering creativity and collaboration. Proximity to leading research institutions and hospitals.
Gleamer fosters a dynamic, mission-driven, and innovative work culture. Employees are passionate about leveraging AI to solve real-world healthcare challenges, emphasizing collaboration, scientific rigor, and continuous learning.
The Paris location provides access to a rich talent pool in AI and medical research, and its central European position facilitates engagement with the European healthcare market and regulatory bodies.
Gleamer operates with a global vision, headquartered in Paris, France, with a significant subsidiary in the USA (Boston, MA) and presence in Germany. Their AI solutions are deployed in hospitals and imaging centers across multiple continents, including Europe, North America, the Middle East, and Asia-Pacific. This widespread adoption is supported by a network of distribution partners and direct sales efforts, ensuring their technology reaches radiologists worldwide to improve diagnostic workflows and patient care.
78 Rue de Richelieu
Paris
Île-de-France
France
Address: One Boston Place, Suite 2600, Boston, MA 02108, USA (Gleamer Inc.)
To establish and expand Gleamer's footprint in the significant United States healthcare market, engage with key opinion leaders, and tailor solutions to meet regional needs.
Address: Specific address not publicly listed, likely regional sales/support presence.
To strengthen Gleamer's market penetration in Germany, a key European healthcare market, and provide localized support to customers.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, GLEAMER' leadership includes:
GLEAMER has been backed by several prominent investors over the years, including:
Gleamer's executive team has seen strategic additions to bolster its commercial and financial leadership as the company scales. No major executive departures have been publicly noted in the last 12 months, indicating stability in the core leadership.
Discover the tools GLEAMER uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Gleamer likely utilizes standard professional email formats. Based on common patterns for tech companies and their domain (gleamer.ai), the most probable format is [first_initial][last]@gleamer.ai or [first].[last]@gleamer.ai.
[first_initial][last]@gleamer.ai
Format
jdoe@gleamer.ai
Example
90%
Success rate
Business Wire • November 27, 2023
Gleamer announced its BoneView® AI software for trauma imaging is now accessible through Aidoc's aiOS™ platform, aiming to streamline AI integration for healthcare providers and enhance radiologists' access to fracture detection tools....more
gleamer.ai • July 10, 2023
Gleamer secured a new CE mark under the European Medical Device Regulation (MDR) for BoneView®, its AI tool for detecting fractures in X-rays. This certification affirms its adherence to stringent EU quality and safety standards....more
TechCrunch • March 21, 2022
Gleamer successfully raised €27 million in a Series B funding round co-led by Supernova Invest and Heal Capital. The funds are aimed at accelerating the commercial rollout of its existing AI radiology solutions and developing new ones for CT scans and mammography, as well as expanding its international presence, particularly in the U.S....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including GLEAMER, are just a search away.